Literature DB >> 2885882

Anti-apomorphine effects of phenothiazine drug metabolites.

E Morel, K G Lloyd, S G Dahl.   

Abstract

The potencies in producing muscle relaxation, and in antagonizing apomorphine-induced climbing and hypothermia in mice, were examined for chlorpromazine, levomepromazine and their main metabolites, and for fluphenazine and 7-hydroxy fluphenazine. 3-Hydroxy chlorpromazine was more potent than chlorpromazine in antagonizing apomorphine-induced climbing, while levomepromazine and 3-hydroxy levomepromazine were equipotent in this test. The 3-hydroxy metabolites of chlorpromazine and levomepromazine were more potent than the parent compounds in antagonizing hypothermia, and had significantly weaker muscle relaxant effects than the parent compounds. The 7-hydroxy and N-monodesmethyl metabolites were generally less potent that the parent compounds in antagonizing apomorphine-induced effects. N-Monodesmethyl levomepromazine had a pronounced muscle relaxant effect, like levomepromazine itself. The sulphoxide metabolites of chlorpromazine and levomepromazine were inactive in all tests. Their potencies in these tests indicate that among the metabolites 7-hydroxy chlorpromazine, N-monodesmethyl chlorpromazine and 3-hydroxy levomepromazine, which have all been identified in plasma from patients, may contribute to the antipsychotic effects of the drugs, and furthermore that N-monodesmethyl levomepromazine may contribute to the sedative effects of levomepromazine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885882     DOI: 10.1007/bf00215481

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.

Authors:  P Protais; J J Bonnet; J Costentin
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding.

Authors:  P A Hals; H Hall; S G Dahl
Journal:  Eur J Pharmacol       Date:  1986-06-24       Impact factor: 4.432

3.  Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey.

Authors:  J Dreyfuss; J J Ross; E C Schreiber
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

4.  Methods for study of fluphenazine kinetics in man.

Authors:  R Whelpton; S H Curry
Journal:  J Pharm Pharmacol       Date:  1976-12       Impact factor: 3.765

5.  Effects of levomepromazine, chlorpromazine and their sulfoxides on isolated rat atria.

Authors:  S Dahl; H Refsum
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

Review 6.  Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.

Authors:  S G Dahl
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

7.  Identification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man.

Authors:  H Johnsen; S G Dahl
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

8.  Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.

Authors:  S G Dahl; H Hall
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding.

Authors:  S G Dahl; E Hough; P A Hals
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

10.  3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.

Authors:  I Creese; A A Manian; T D Prosser; S H Snyder
Journal:  Eur J Pharmacol       Date:  1978-02-01       Impact factor: 4.432

View more
  4 in total

1.  Tales from the war on error: the art and science of curating QSAR data.

Authors:  Marvin Waldman; Robert Fraczkiewicz; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2015-08-20       Impact factor: 3.686

2.  Region specific distribution of levomepromazine in the human brain.

Authors:  J Kornhuber; H Weigmann; J Röhrich; J Wiltfang; S Bleich; I Meineke; R Zöchling; S Härtter; P Riederer; C Hiemke
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

3.  Structural changes by sulfoxidation of phenothiazine drugs.

Authors:  S G Dahl; P A Kollman; S N Rao; U C Singh
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

4.  Metabolism of levomepromazine in man.

Authors:  P A Hals; S G Dahl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.